Eye Health Supplement

Preservision AREDS

134 adverse event reports submitted to the FDA · 2008–2025 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 134 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Blood pressure increased
12
Dysphagia
12
Choking
10
Blindness
8
Constipation
7
Condition aggravated
7
Dyspnoea
7
Macular degeneration
7
Visual impairment
6
Lung neoplasm malignant
6

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Other Serious or Important Medical Event 113
Hospitalization 21
Visited a Health Care Provider 18
Other Serious Outcome 10
Visited Emergency Room 5
Death 3
Life Threatening 3
Other Outcome 3
Required Intervention 1
Disability 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
0
18–34
0
35–49
0
50–64
4
65–79
40
80+
65
Unknown
25

109 reports had age data; 25 unknown.

Gender

Male
38
Female
94
Unknown/Not Reported
2

Reports by Year

Annual report counts from 2008–2025. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Hover bars for exact counts.

← View all PreserVision products in FDA data

Related Products

Preservision Lutein (32) Preservision (26)

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data